Results 271 to 280 of about 30,002 (370)

Nomograms Based on Blood-Based Biomarkers for Predicting Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients. [PDF]

Mediators Inflamm
Wang S, Feng Y, Ling J, Zhao X, Hu Y, Hou T, Xie Y.   +6 more
europepmc   +1 more source

Platelets: Novel Biomaterials for Cancer Diagnosis and Therapeutic Delivery

MedComm – Biomaterials and Applications, Volume 4, Issue 2, June 2025.
Platelets, particularly tumor‐educated platelets (TEPs), play a crucial role in cancer diagnosis and treatment. TEPs undergo molecular changes in RNA and protein profiles, making them valuable biomarkers for diagnosis, prognosis, and monitoring. In nanomedicine, platelets serve as drug carriers in tumor‐targeted nanomaterials, enhancing specificity and
Xin Wang, Jie Chen, Hubing Shi
wiley   +1 more source

Computed Tomographic Characteristics Associated With Novel Case of Ossified Pharyngeal Dermoid Cyst in Juvenile Canine. [PDF]

Vet Radiol Ultrasound
Kalphat-Losego K, Giglio RF.
europepmc   +1 more source

Bacterial Outer Membrane Vesicles: From Physics to Clinical

MedComm – Biomaterials and Applications, Volume 4, Issue 2, June 2025.
A review of an introduction to the mechanisms of formation of OMVs, their action on bacteria and relationship to disease, vaccines, biomonitoring, drug delivery and regenerative medicine in the clinic. ABSTRACT Bacterial outer membrane vesicles (OMVs) are nanoscale vesicular structures naturally produced by Gram‐negative bacteria during growth.
Jun Zhou, Shuang Zou, Derong Dai, Liqing He, Xingyu Mou, Ninglin Zhao, Hong Li, Rui Bao   +7 more
wiley   +1 more source

Transmission of an Epstein-Barr Strain Common in South-East China to a Western Individual. [PDF]

J Med Virol
Poirey R, Delecluse HJ, Delecluse S.
europepmc   +1 more source

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Background Rhabdomyosarcoma (RMS) is the most common pediatric head and neck soft‐tissue sarcoma. Intergroup Rhabdomyosarcoma Study I–IV demonstrated that patients with alveolar RMS (ARMS), Group III disease, or clinically involved regional lymph nodes had a worse prognosis.
Jamie M. Aye, Wei Xue, Zhengya Gao, Matthew Ladra, Daniel J. Indelicato, Anthony Sheyn, Roshni Dasgupta, Michael A. Arnold, Archana Shenoy, Corinne M. Linardic, Rajkumar Venkatramani   +10 more
wiley   +1 more source

Integrative analysis of taurine metabolism-related genes prognostic signature with immunotherapy and identification of ABCB1 and GORASP1 as key genes in nasopharyngeal carcinoma. [PDF]

Amino Acids
Feng Z, Yang Y, Luo W, Li J, Xie Z, Zuo L, Duan M, Zuo D, Mo R, Tang X, Yi S, He X, Liu F, Ma N, He F.   +14 more
europepmc   +1 more source

Immunotherapy combined with chemotherapy without locoregional radiotherapy in <i>de novo</i> metastatic nasopharyngeal carcinoma: two case reports and a literature review. [PDF]

Front Immunol
Gao Y, Shi X, He J, Yao H, Yu G, Zhao L, Ma Y, Zheng H, Zhu M, Zhang C.   +9 more
europepmc   +1 more source

Establishing a Risk Prediction Model for Nasopharyngeal Carcinoma Based on Anti-BNLF2b Serological Biomarkers: A Retrospective Study. [PDF]

Int J Med Sci
Shao H, Chen M, Xiao Y, Xu L, Cao H, Hong B, Qian Y.   +6 more
europepmc   +1 more source

Patient Characteristics and Treatment Outcomes of Nasopharyngeal Carcinoma in Nonendemic Regions.

JAMA Netw Open
Alsavaf MB, Marquardt M, Abouammo MD, Xu M, Elguindy A, Grecula J, Baliga S, Konieczkowski D, Gogineni E, Bhateja P, Rocco JW, Old MO, Blakaj DM, Carrau RL, VanKoevering KK, Bonomi M.   +15 more
europepmc   +1 more source